IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Astrazeneca PLC

Q4 2024 vs Q3 2025

Comparing institutional holders between quarters

Quarters

Q3 2025Q4 2024Q2 2023Q4 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
DCF Advisers, LLC
INCREASED
Shares45,800 from 8,000
Change+37,800 (+473%)
Value$3.5M (+$3.0M)
Filed 2025-11-12
Status
DCF Advisers, LLC
INCREASED45,8008,000+37,800+473%$524.2K$3.5M+$3.0M2025-11-12
Showing 1 of 1 institutions